Pages that link to "Q37433463"
Jump to navigation
Jump to search
The following pages link to TRAIL on trial: preclinical advances in cancer therapy (Q37433463):
Displaying 50 items.
- Clinical perspectives of TRAIL: insights into central nervous system disorders (Q26766570) (← links)
- Cancer stem cell targeted therapy: progress amid controversies. (Q26779931) (← links)
- CD317 Promotes the survival of cancer cells through apoptosis-inducing factor (Q27468925) (← links)
- NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer? (Q28078448) (← links)
- Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapy (Q28115758) (← links)
- TRAIL activates JNK and NF-κB through RIP1-dependent and -independent pathways (Q28384960) (← links)
- A novel capsid-modified oncolytic recombinant adenovirus type 5 for tumor-targeting gene therapy by intravenous route (Q28817910) (← links)
- Identification of miRNA-7 by genome-wide analysis as a critical sensitizer for TRAIL-induced apoptosis in glioblastoma cells (Q30854013) (← links)
- The structure of the death receptor 4-TNF-related apoptosis-inducing ligand (DR4-TRAIL) complex (Q31814863) (← links)
- Sulforaphane and TRAIL induce a synergistic elimination of advanced prostate cancer stem-like cells (Q33637076) (← links)
- Assessment of concentrations of sTRAIL ligand and its receptors sTRAIL-R1 and sTRAIL-R2 - markers monitoring the course of the extrinsic pathway of apoptosis induction: potential application in ovarian cancer diagnostics (Q33645912) (← links)
- Antitumor Activity of a Mesenchymal Stem Cell Line Stably Secreting a Tumor-Targeted TNF-Related Apoptosis-Inducing Ligand Fusion Protein (Q33658976) (← links)
- TRAIL mutant membrane penetrating peptide alike-MuR6-TR enhances the antitumor effects of TRAIL in pancreatic carcinoma both in vitro and in vivo (Q33674881) (← links)
- Neural stem cell therapy for cancer (Q33704489) (← links)
- Role of Bcl-xL/Beclin-1 in synergistic apoptotic effects of secretory TRAIL-armed adenovirus in combination with mitomycin C and hyperthermia on colon cancer cells (Q34333852) (← links)
- PARP13 regulates cellular mRNA post-transcriptionally and functions as a pro-apoptotic factor by destabilizing TRAILR4 transcript (Q34493442) (← links)
- Targeting c-Met receptor overcomes TRAIL-resistance in brain tumors (Q35153149) (← links)
- Controlled delivery of BID protein fused with TAT peptide sensitizes cancer cells to apoptosis (Q35344969) (← links)
- Antiangiogenic variant of TSP-1 targets tumor cells in glioblastomas (Q35653261) (← links)
- Systemic anticancer neural stem cells in combination with a cardiac glycoside for glioblastoma therapy (Q35679830) (← links)
- Drug-releasing mesenchymal cells strongly suppress B16 lung metastasis in a syngeneic murine model (Q38635960) (← links)
- Targeting breast to brain metastatic tumours with death receptor ligand expressing therapeutic stem cells (Q35974503) (← links)
- Ethanolic extract of Descurainia sophia seeds sensitizes A549 human lung cancer cells to TRAIL cytotoxicity by upregulating death receptors (Q35978089) (← links)
- RIP1 Cleavage in the Kinase Domain Regulates TRAIL-Induced NF-κB Activation and Lymphoma Survival (Q36033375) (← links)
- Inhibition of never in mitosis A (NIMA)-related kinase-4 reduces survivin expression and sensitizes cancer cells to TRAIL-induced cell death (Q36125103) (← links)
- Cyproterone acetate enhances TRAIL-induced androgen-independent prostate cancer cell apoptosis via up-regulation of death receptor 5 (Q36300065) (← links)
- A promising "TRAIL" of tanshinones for cancer therapy (Q36332681) (← links)
- Delivery of tumor-homing TRAIL sensitizer with long-acting TRAIL as a therapy for TRAIL-resistant tumors (Q36395984) (← links)
- Nanoparticle-Mediated Target Delivery of TRAIL as Gene Therapy for Glioblastoma (Q36470507) (← links)
- The pyrrolo-1,5-benzoxazepine, PBOX-15, enhances TRAIL‑induced apoptosis by upregulation of DR5 and downregulation of core cell survival proteins in acute lymphoblastic leukaemia cells (Q36992184) (← links)
- Characterization of MUDENG, a novel anti-apoptotic protein (Q37096238) (← links)
- Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL. (Q37238771) (← links)
- Androgen deprivation therapy sensitizes triple negative breast cancer cells to immune-mediated lysis through androgen receptor independent modulation of osteoprotegerin (Q37269053) (← links)
- Death receptor 5 (DR5) and a 5-gene apoptotic biomarker panel with significant differential diagnostic potential in colorectal cancer (Q37402581) (← links)
- Advanced new strategies for metastatic cancer treatment by therapeutic stem cells and oncolytic virotherapy (Q37629088) (← links)
- Predicting the cell death responsiveness and sensitization of glioma cells to TRAIL and temozolomide (Q37641600) (← links)
- Stem cell-based therapies for cancer treatment: separating hope from hype (Q38245163) (← links)
- Regulation of TRAIL-receptor expression by the ubiquitin-proteasome system. (Q38260461) (← links)
- Tumor necrosis factor-related apoptosis-inducing ligand in vascular inflammation and atherosclerosis: a protector or culprit? (Q38275877) (← links)
- Engineering Stem Cells for Biomedical Applications. (Q38378499) (← links)
- Drug Loaded Gingival Mesenchymal Stromal Cells (GinPa-MSCs) Inhibit In Vitro Proliferation of Oral Squamous Cell Carcinoma (Q38637527) (← links)
- Differences and Similarities in TRAIL- and Tumor Necrosis Factor-Mediated Necroptotic Signaling in Cancer Cells (Q38751590) (← links)
- Caffeic acid phenethyl ester enhances TRAIL-mediated apoptosis via CHOP-induced death receptor 5 upregulation in hepatocarcinoma Hep3B cells (Q38766692) (← links)
- Trichostatin A potentiates TRAIL-induced antitumor effects via inhibition of ERK/FOXM1 pathway in gastric cancer (Q38797635) (← links)
- Preparation and characterization of a novel variant of human tumor necrosis factor-related apoptosis-inducing ligand from the rhesus monkey, Macaca mulatta (Q38816367) (← links)
- Stem cell-based therapies for tumors in the brain: are we there yet? (Q38855638) (← links)
- Delivery of improved oncolytic adenoviruses by mesenchymal stromal cells for elimination of tumorigenic pancreatic cancer cells (Q38914555) (← links)
- Engineered adenoviruses combine enhanced oncolysis with improved virus production by mesenchymal stromal carrier cells (Q38918317) (← links)
- PARP inhibition restores extrinsic apoptotic sensitivity in glioblastoma (Q38926314) (← links)
- Apoptosis in Primary Hyperparathyroidism. (Q39211022) (← links)